SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-003688
Filing Date
2024-05-20
Accepted
2024-05-20 15:34:01
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MARCH 2024 sunshine_i10q-33124.htm   iXBRL 10-Q 566863
2 CERTIFICATION sunshine_ex3101.htm EX-31.1 13754
3 CERTIFICATION sunshine_ex3102.htm EX-31.2 13738
4 CERTIFICATION sunshine_ex3201.htm EX-32.1 5942
5 GRAPHIC image_001.jpg GRAPHIC 6215
  Complete submission text file 0001683168-24-003688.txt   3717662

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sbfm-20240331.xsd EX-101.SCH 34436
7 XBRL CALCULATION FILE sbfm-20240331_cal.xml EX-101.CAL 45777
8 XBRL DEFINITION FILE sbfm-20240331_def.xml EX-101.DEF 148398
9 XBRL LABEL FILE sbfm-20240331_lab.xml EX-101.LAB 279928
10 XBRL PRESENTATION FILE sbfm-20240331_pre.xml EX-101.PRE 244997
65 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-33124_htm.xml XML 373916
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 24964121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)